Structure and function of an effector domain in antiviral factors and tumor suppressors SAMD9 and SAMD9L
Shuxia Peng(Oklahoma State University), Yan Xiang(Sichuan University), Xiangzhi Meng(University of California, Los Angeles), Marisol Morales(The University of Texas at San Antonio Health Science Center), Junpeng Deng(Oklahoma State University), Shu‐Bing Qian(Cornell University), Yuanhui Mao(Guangxi University of Chinese Medicine), Juhi Chaturvedi(Oklahoma State University), Fushun Zhang(The University of Texas at San Antonio Health Science Center), Jaime Coronado(The University of Texas at San Antonio Health Science Center), Prabhat Kumar Pathak(Oklahoma State University)
Cited by 49
Related Papers
XBP1, Downstream of Blimp-1, Expands the Secretory Apparatus and Other Organelles, and Increases Protein Synthesis in Plasma Cell Differentiation
|Immunity|2004|1.1k
Structure and inhibition of the SARS-CoV-2 main protease reveal strategy for developing dual inhibitors against M <sup>pro</sup> and cathepsin L
|Science Advances|2020|400
Clofazimine broadly inhibits coronaviruses including SARS-CoV-2
|Nature|2021|216
Discovery of SARS-CoV-2 Papain-like Protease Inhibitors through a Combination of High-Throughput Screening and a FlipGFP-Based Reporter Assay
|ACS Central Science|2021|200
The <i>in vitro</i> antiviral activity of lactoferrin against common human coronaviruses and SARS-CoV-2 is mediated by targeting the heparan sulfate co-receptor
|Emerging Microbes & Infections|2021|190